Πλοήγηση ανά Θέμα "brain derived neurotrophic factor"
Αποτελέσματα 1-11 από 11
-
Association between brain-derived neurotrophic factor (BDNF) levels in 2 nd trimester amniotic fluid and fetal development
(2018)The development of the fetal nervous system mirrors general fetal development, comprising a combination of genetic resources and effects of the intrauterine environment. Our aim was to assess the 2 nd trimester amniotic ... -
BDNF rs6265 (Val66Met) Polymorphism as a Risk Factor for Blepharospasm
(2019)A few genetic variants are implicated in the development of blepharospasm (BSP). The precise role of the rs6265 on the brain-derived neurotrophic factor (BDNF) gene on BSP remains controversial. The effect of rs6265 on BSP ... -
Cognitive function and exercise training for chronic renal disease patients: A literature review
(2015)Objective: Cognitive impairment is very often noted in patients with Chronic Kidney Disease (CKD). Even though, exercise is considered to be a quantifiable activity that improves cognition in animals and humans, it seems ... -
The effects of training with high-speed interval running on muscle performance are modulated by slope
(2021)We examined changes in selected muscle performance parameters after 8 weeks of interval training using two opposite running inclinations. We hypothesized that the uphill training will affect endurance muscle performance ... -
Exercise works for depression: Bridging the implementation gap and making exercise a core component of treatment
(2017)[No abstract available] -
Incorporating Biomarkers in COPD Management: The Research Keeps Going
(2022)Globally, chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity and mortality, having a significant socioeconomic effect. Several molecular mechanisms have been related to COPD including chronic ... -
Ketogenic therapy for Parkinson's disease: A systematic review and synthesis without meta-analysis of animal and human trials
(2022)Objective: The aim of the present systematic review was to assess the efficacy of ketogenic therapy in Parkinson's disease (PD), using all available data from randomized controlled trials (RCTs) on humans and animal studies ... -
Microbiome in multiple sclerosis; where are we, what we know and do not know
(2020)An increase of multiple sclerosis (MS) incidence has been reported during the last decade, and this may be connected to environmental factors. This review article aims to encapsulate the current advances targeting the study ... -
Risk factor genes in patients with dystonia: A comprehensive review
(2019)Background: Dystonia is a movement disorder with high heterogeneity regarding phenotypic appearance and etiology that occurs in both sporadic and familial forms. The etiology of the disease remains unknown. However, there ... -
Therapeutic application of rTMS in neurodegenerative and movement disorders: A review
(2022)Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that makes use of the magnetic field generated when an electric current passes through a magnetic coil placed over the scalp. It can be ... -
Val66Met polymorphism is associated with decreased likelihood for pediatric headache and migraine
(2021)Background: Migraine is a complex multifactorial disorder and its pathogenesis still remains unclear. Evidence suggests the involvement of the activated trigeminovascular pathway, in which BDNF seems to play an important ...